News

Faldaprevir regimen is effective as first treatment for HCV genotype 1

Publish date: October 29, 2013

 

AT THE ACG ANNUAL MEETING

*This article was updated October 30, 2013.

Pages

Recommended Reading

Referral approach promotes next-day ID consultation for cellulitis
MDedge Internal Medicine
MSSA patients tolerate cefazolin over nafcillin
MDedge Internal Medicine
Flu vaccine linked to lower cardiovascular risk
MDedge Internal Medicine
NCQA: Docs still overusing antibiotics
MDedge Internal Medicine
High-dose flu vaccine protects seniors better than regular dose
MDedge Internal Medicine
FDA panel backs approval of new protease inhibitor for hepatitis C
MDedge Internal Medicine
New HPV vaccine promises to prevent 85% of invasive cervical cancer
MDedge Internal Medicine
HPV vaccine uptake low in autoimmune disease patients
MDedge Internal Medicine
Novel antiviral for chronic hepatitis C backed for approval
MDedge Internal Medicine
Increasing proportion of musculoskeletal infections involve MRSA
MDedge Internal Medicine